52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period

Clinical trial NCT00575588 · COMPLETED

Trial details

NCT number: NCT00575588
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2007-12-01
Primary completion: 2009-08-01
Enrollment: 891

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.